Kenneth D.R. Setchell

Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements

Kenneth D.R. Setchell, Nadine M. Brown, Pankaj B. Desai et al. · Journal of Nutrition · 2001 · 962 citations · Full text

Nutrition, Pure Isoflavones, Nutrient Bioavailability +3

Genistein, daidzein, and their .beta.-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets

Lori Coward, Neil C. Barnes, Kenneth D.R. Setchell et al. · Journal of Agricultural and Food Chemistry · 1993 · 880 citations

Food Chemistry, Asian Dietslori, .Beta.-glycoside Conjugates +12

Exposure of infants to phyto-oestrogens from soy-based infant formula

Kenneth D.R. Setchell, Linda Zimmer-Nechemias, Jinnan Cai et al. · The Lancet · 1997 · 704 citations

Endocrine Disruptors, Developmental Toxicology, Infant Nutrition +6

Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability

Kenneth D.R. Setchell, Nadine M. Brown, Linda Zimmer-Nechemias et al. · American Journal of Clinical Nutrition · 2002 · 615 citations · Full text

Nutrition, Soy Isoflavone Glycosides, Intestinal Metabolism +10

S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora1–4,

Kenneth D.R. Setchell, Carlo Clerici, Edwin D. Lephart et al. · American Journal of Clinical Nutrition · 2005 · 455 citations

Soy Isoflavone Metabolite, Estrogen Receptor β, Biochemistry +8